Research publications

Establishing a global quality of care benchmark report

Sampurno F, Cally J, Opie JL, Kannan A, Millar JL, Finelli A, Vickers AJ, Moore CM, Kowalski C, Foster C, Barocas DA, Galvin D, Van Basten JP, Gore JL, Ferencz J, Lawson KA, Ghani KR, Kwan L, Saarela O, Connor SE, Dieng S, Linsell S, Soeterik TFW, Villanti P, Litwin MS, Evans SM

(2021), HEALTH INFORM J, 27(2), 14604582211015704

DOI: 10.1177/14604582211015704

Radiation oncology training in Australia and New Zealand during and beyond the COVID-19 pandemic - lessons learnt and opportunities for improvement

Ong WL, Weerasinghe C

(2021), J MED IMAG RADIAT ON, 65(6), 826-8

DOI: 10.1111/1754-9485.13245

Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?

O'Callaghan M, Papa N, Pase M, Frydenberg M, Mark S, Moretti K, Maqsood S, Smith D, Walker T, White C, Millar J, On behalf of the Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ)

(2021), BJU Int, 128(Suppl 1), 6-8

DOI: 10.1111/bju.15366

A patient-centred approach to determine optimal supportive care across the cancer trajectory: a cross-sectional study

Turon H, Hill D, Watson R, Hobden B, Millar J, Sanson-Fisher R

(2021), Eur J Cancer Care, 30(5), e13455

DOI: 10.1111/ecc.13455

Measuring the dose in bone for spine stereotactic body radiotherapy,

Shaw M, Lye J, Alves A, Hanlon M, Lehmann J, Supple J, Porumb C, Williams I, Geso M, Brown R

(2021), PHYS MEDICA, 84, 265-73

DOI: 10.1016/j.ejmp.2021.03.011

Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis

Papa N, Perera M, Murphy DG, Lawrentschuk N, Evans M, Millar JL, Bolton D

(2021), J MED IMAG RADIAT ON, 65(6), 649-54

DOI: 10.1111/1754-9485.13162

Choosing wisely in radiation therapy for breast cancer: Time lag in adoption of hypofractionated radiation therapy in Victoria

Ong WL, Khor R, Chao M, Milne RL, Millar J, Foroudi F

(2021), J MED IMAG RADIAT ON, 65(2), 224-32

DOI: 10.1111/1754-9485.13155

Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma

Espensen CA, Kilgaard JF, Appelt AL, Fog LS, Herault J, Maschi C, Caujolle JP, Thariat J

(2021), Ophthalmology, 128(1), 152-61

DOI: 10.1016/j.ophtha.2020.06.030

HDR brachytherapy well chamber calibration and stability evaluated over twenty years of clinical use

Keehan S, Smith RL, Butler D

(2021), Brachytherapy, 20(1), 257-64

DOI: 10.1016/j.brachy.2020.08.017

Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016

Ong WL, Evans SM, Evans M, Tacey M, Dodds L, Kearns P, Milne RL, Foroudi F, Millar J

(2021), Eur Urol Oncol, 4(2), 319-22

DOI: 10.1016/j.euo.2019.04.006

Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards

Segelov E, Carrington C, Aranda S, Currow D, Zalcberg JR, Heriot AG, Mileshkin L, Coutsouvelis J, Millar JL, Collopy BT, Emery JD, Zhang P, Cooper S, O'Kane C, Wale J, Hancock SJ, Sulkowski A, Bashford J

(2021), MED J AUSTRALIA, 214(11), 528-31

DOI: 10.5694/mja2.51087

3D image-guided treatment planning for Ruthenium-106 brachytherapy of choroidal melanomas

Espensen CA, Kiilgaard JF, Klemp K, Gothelf A, Appelt AL, Fog LS

(2021), Acta Ophthalmol, 99(5), E654-60

DOI: 10.1111/aos.14663

Development of an automated radiotherapy dose accumulation workflow for locally advanced high-risk prostate cancer - A technical report

Ong A, Knight K, Panettieri V, Dimmock M, Tuan JKL, Tan HQ, Master Z, Wright C

(2021), Journal of Medical Radiation Sciences, 68(2), 203-10

DOI: 10.1002/jmrs.442

Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

McNeil JJ, Gibbs P, Orchard SG, Lockery JE, Bernstein WB, Cao Y, Ford L, Haydon A, Kirpach B, Macrae F, McLean C, Millar J, Murray AM, Nelson MR, Polekhina G, Reid CM, Richmond E, Rodríguez LM, Shah RC, Tie J, Umar A, Londen GJV, Ronaldson K, Wolfe R, Woods RL, Zalcberg J, Chan AT; ASPREE Investigator Group

(2021), JNCI-J NATL CANCER I, 113(3), 258-65

DOI: 10.1093/jnci/djaa114

Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia

Ong, Wee Loon; Foroudi, Farshad; Milne, Roger L.; Millar, Jeremy L.

(2020), INT J RADIAT ONCOL, 106(1), 61-66.

DOI: 10.1016/j.ijrobp.2019.08.061

Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison

Poder J, Smith R, Haworth A

(2020), Brachytherapy, 19(1), 119-25

DOI: 10.1016/j.brachy.2019.10.001

Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial

Ratnayake G, Reinwald S, Shackleton M, Moore M, Voskoboynik M, Ruben J, van Zelm MC, Yu D, Ward R, Smith R, Haydon A, Senthi S

(2020), INT J RADIAT ONCOL, 108(1), 150-6

DOI: 10.1016/j.ijrobp.2020.05.022

A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patients

Brooker, Joanne; Julian, John; Millar, Jeremy; Prince, H. Miles; Kenealy, Melita; Herbert, Kirsten; Graham, Annette; Smith, Robin; Kissane, David; Taylor, Karen; Frydenberg, Mark; Porter, Ian; Fletcher, Jane; Haines, Ian; Burney, Sue

(2020), PALLIAT SUPPORT CARE, 18(2), 130-140.

DOI: 10.1017/S1478951519000737

(Dis)concordance of comorbidity data and cancer status across administrative datasets, medical charts, and self-reports

Sheriffdeen, A.; Millar, J. L.; Martin, C.; Evans, M.; Tikellis, G.; Evans, S. M.

(2020), BMC HEALTH SERV RES, 20(1),

DOI: 10.1186/s12913-020-05713-5

Stereotactic radiosurgery for managing brain metastases in Victoria, 2012–2017

Ong, Wee Loon; Kang, Therese Ming Jung; Ratnayake, Gishan; Wada, Morikatsu; Ruben, Jeremy; Senthi, Sashendra; Milne, Roger L.; Millar, Jeremy L.; Foroudi, Farshad

(2020), MED J AUSTRALIA, 212(11), 526-527

DOI: 10.5694/mja2.50573

Publication Details